MBX Biosciences, Inc. (MBX) earnings
MBX earnings moved a median of +1.39% by the close. Quarterly and annual MBX reports and results, each read against the price at its own news timestamp. Back to the MBX overview →
14 measured MBX earnings events.
Where these MBX earnings landedvs 14 measured MBX earnings reactions
| Middle 50% of MBX earnings reactions | -1.25% to +7.12% |
|---|---|
| Median reaction (to close) | +1.39% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 MBX earnings events with a measured close landed between -1.25% and +7.12%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MBX Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.69% | +1.39% | |
| MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights | Press release | +0.69% | +1.39% | |
| Form 10-Q MBX Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.06% | +8.47% | |
| MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights | Press release | -1.06% | +8.47% | |
| Form 10-K MBX Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.15% | -1.55% | |
| Form 10-Q MBX Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.09% | +9.81% | |
| MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | +2.09% | +9.81% | |
| Form 10-Q MBX Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.02% | -6.23% | |
| MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | -2.02% | -6.23% | |
| Form 10-Q MBX Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.07% | -0.36% | |
| MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | +1.07% | -0.36% | |
| Form 10-K MBX Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.55% | -3.80% | |
| Form 10-Q MBX Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.58% | +3.06% | |
| MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +0.58% | +3.06% |
Keep exploring
More MBX: analyst actions → · SEC filings → · MBX overview →